As of May 2022 LivaNova has a market cap of $3.57 Billion. This makes LivaNova the world's 2713th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to mesure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2022 | $3.47 B | -25.3% |
2021 | $4.65 B | 44.45% |
2020 | $3.22 B | -11.84% |
2019 | $3.65 B | -17.13% |
2018 | $4.40 B | 14.44% |
2017 | $3.85 B | 75.67% |
2016 | $2.19 B | -24.4% |
2015 | $2.90 B | 98.03% |
2014 | $1.46 B | -17% |
2013 | $1.76 B | 21.22% |
2012 | $1.45 B | 57.38% |
2011 | $0.92 B | 6.46% |
2010 | $0.86 B | 53.19% |
2009 | $0.56 B | 25.42% |
2008 | $0.45 B | 25.75% |
2007 | $0.35 B | -32.22% |
2006 | $0.53 B | -34.4% |
2005 | $0.80 B | 63.42% |
2004 | $0.49 B | -32.59% |
2003 | $0.73 B | 81.13% |
2002 | $0.40 B | -29.36% |
2001 | $0.57 B |
On May 15th, 2022 the market cap of LivaNova was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
![]() Merit Medical MMSI | $3.44 B | -3.64% | ๐บ๐ธ USA |
![]() Inari Medical
NARI | $3.25 B | -8.97% | ๐บ๐ธ USA |